Trials / Terminated
TerminatedNCT00663065
A Study of the Safety of PAZ-417 in Healthy Elderly Adults
An Ascending Multiple-Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of PAZ-417 Administered Orally to Elderly Subjects
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
This is study to determine the safety of PAZ-417 in healthy adults over 65.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PAZ-417 |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2008-04-21
- Last updated
- 2009-08-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00663065. Inclusion in this directory is not an endorsement.